Clinical trial
Body Fat Mass as Predictors of Survival in Hemodialysis Patients and Its Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines in Chronic Hemodialysis Patients: a Prospective Study.
NCT02799719 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Body Fat Mass as Predictors of Survival in Hemodialysis Patients and Its Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines in Chronic Hemodialysis Patients: a Prospective Study.
- Lead sponsor
- Tungs' Taichung Metroharbour Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- December 31, 2016
- Enrollment
- 65 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
overweight and obesity